The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“LDLR is a receptor that binds to apolipoprotein B and apoE in the periphery to facilitate the uptake of cholesterol-laden lipoproteins by cells [38].”
From Measurement of apolipoprotein E and amyloid β clearance rates in the mouse brain using bolus stable isotope labeling (2012) · cites this paper as [38]
In the citing paper
“Ldlr is normally localized to the plasma membrane where it binds extracellular ApoE lipoproteins followed by endocytosis and subsequent release of bound lipids in the lysosome (62).”
From Regulation of astrocyte lipid metabolism and ApoE secretion by the microglial oxysterol, 25-hydroxycholesterol (2023) · cites this paper as [62]
In the citing paper
“LDLR is a cell surface glycoprotein that plays an important role in mediating the removal of cholesterol and cholesteryl ester-containing low-density lipoprotein (LDL) particles from the circulation (Brown and Goldstein, 1986; Herz and Bock, 2002).”
From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Brown and Goldstein, 1986
In the citing paper
“LDL is catabolized by the liver via the LDL receptor (LDLR), which binds APOB and removes LDL from circulation and traffics it to the endosomal system for degradation (15).”
From Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism (2012) · cites this paper as [15]
In the citing paper
“internalized LDL is released from LDLR in acidic compartments (29, 30)”
From The small GTPase RAB10 regulates endosomal recycling of the LDL receptor and transferrin receptor in hepatocytes (2022) · cites this paper as [30]
In the citing paper
“Cholesterol derived from low-density lipoprotein (LDL) is taken into cells through endocytosis mediated by LDL receptors (LDLRs) (1).”
From Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine (2020) · cites this paper as [1]
In the citing paper
“LDL-derived cholesterol is taken up by LDLRs and released in lysosomes (1).”
From Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine (2020) · cites this paper as [1]
In the citing paper
“A number of scholars reported that LDLR is a major determinant of circulating levels of LDL.[16][17][18]”
From USP16 Regulates the Stability and Function of LDL receptor by Deubiquitination (2020) · cites this paper as [18]
In the citing paper
“Upon binding of plasma LDLs, cell surface LDLRs are internalized and transported to endosomes, where low pH causes LDLR-LDL dissociation1.”
From Phosphatidylinositol-(4,5)-Bisphosphate Regulates Plasma Cholesterol Through LDL (Low-Density Lipoprotein) Receptor Lysosomal Degradation (2020) · cites this paper as [1]
In the citing paper
“As a transmembrane glycoprotein, low-density lipoprotein receptor (LDLR) is abundantly expressed on the surface of hepatocytes, where it facilitates the uptake of LDL cholesterol and maintains the homeostasis of lipid metabolism20,21.”
From ABCC4 impairs the clearance of plasma LDL cholesterol through suppressing LDLR expression in the liver (2025) · cites this paper as [21]
In the citing paper
“Low expression level of low-density lipoprotein receptor (LDLR) in hepatocytes leads to hypercholesterolemia and eventually contributes to atherosclerotic cardiovascular disease (ASCVD).”
From ABCC4 impairs the clearance of plasma LDL cholesterol through suppressing LDLR expression in the liver (2025) · cites this paper as [21]
In the citing paper
“Complete absence or defective LDLRs due to mutations in the LDLR gene cause FH, characterized by an autosomal dominant inheritance of hypercholesterolemia and premature ASCVD (a list of mutations can be found in Table 1)1–4.”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [2]
In the citing paper
“where it is concentrated into clathrin-coated pits to internalize bound LDL by receptor-mediated endocytosis (discussed separately below)2”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [2]
In the citing paper
“Low-density lipoprotein receptor (LDLR) is an integral membrane protein that is most abundantly expressed in the liver, where it binds to and removes LDL-C from the circulation by endocytosis4,5.”
From Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA (2018) · cites this paper as [4]
In the citing paper
“Feedback suppression of SREBP2 pathway by LDLR plays a pivotal role in maintaining the balance of cholesterol levels between liver and blood (Brown and Goldstein, 1986).”
From GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis (2019) · cites this paper as Brown and Goldstein, 1986
In the citing paper
“hepatic cells also play major roles in removing LDL from the circulation”
From Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol (2016) · cites this paper as [7]
In the citing paper
“The main carriers of atherogenic circulating cholesterol in humans are the LDL particles, which are produced mainly by the liver to deliver cholesterol to peripheral tissues”
From Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol (2016) · cites this paper as [7]
In the citing paper
“The balance of serum cholesterol level is determined by dietary intake, synthesis, and catabolism”
From Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol (2016) · cites this paper as [7]
In the citing paper
“LDL clearance from the circulation by LDL receptor (LDLR)-mediated endocytosis by hepatic and peripheral tissues and subsequent feedback regulation of endogenous synthesis of cholesterol is a key determinant of serum LDL level”
From Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol (2016) · cites this paper as [7]
In the citing paper
“Excessive cholesterol in the circulation, upon uptake by the liver via LDL receptor (LDLR)-mediated endocytosis, suppresses endogenous synthesis of cholesterol in the liver”
From Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol (2016) · cites this paper as [7]
In the citing paper
“The expression of liver LDL receptor (LDLR) regulates human plasma LDL-cholesterol (LDL-C) homeostasis”
From A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression (2014) · cites this paper as [2]
In the citing paper
“Following dissociation of the LDLR-LDL complex, LDL is directed to lysosomes whereas the LDLR recycles to the plasma membrane.”
From The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation (2013) · cites this paper as [2]
In the citing paper
“Low density lipoprotein (LDL) cholesterol is taken up into cells via clathrin-mediated endocytosis of the LDL receptor (LDLR).”
From The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation (2013) · cites this paper as [2]
In the citing paper
“LDL, which is derived by peripheral lipolysis of VLDL (very-low-density lipoprotein), is primarily cleared from the circulation in the liver via the LDLR (LDL receptor) pathway.1,2”
From (Pro)renin Receptor Inhibition Reprograms Hepatic Lipid Metabolism and Protects Mice From Diet-Induced Obesity and Hepatosteatosis (2018) · cites this paper as [1]
In the citing paper
“This results in induction of the full set of genes required for de novo biosynthesis of cholesterol via the mevalonate pathway and of the low-density lipoprotein receptor (LDLR) that is required for uptake of LDL-derived cholesterol (7,8).”
From A MARCH6 and IDOL E3 Ubiquitin Ligase Circuit Uncouples Cholesterol Synthesis from Lipoprotein Uptake in Hepatocytes (2016) · cites this paper as [8]
In the citing paper
“The LDLR structure from the N-terminus to the C-terminus includes seven ligand-binding domain repeats, an epidermal growth factor (EGF) precursor homology domain, an O-linked sugar domain, a transmembrane domain, and a cytoplasmic domain”
From ENO1–BACE2-mediated LDLR cleavage promotes liver cancer progression by remodelling cholesterol metabolism (2025) · cites this paper as Brown and Goldstein, 1986
In the citing paper
“Early studies on normal and FH fibroblasts demonstrated that LDLRs, shortly after being synthesized, appear on the cell surface where they gather in coated pits (1).”
In the citing paper
“The low density lipoprotein receptor (LDLR) 2 plays a pivotal role in the regulation of cholesterol metabolism (1).”
In the citing paper
“As noted in the Introduction, LDLR tends to cluster in clathrincoated pits on the cell surface under defined conditions.”
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
Sickle Cell Anemia, a Molecular Disease
Pauling, L., Itano, H. A., Singer, S. J., & Wells, I. C. (1949) · Science · doi:10.1126/science.110.2865.543 · Cited by 2,319
Gilbert, W. (1978) · Nature · doi:10.1038/271501a0 · Cited by 2,300
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Carbohydrate-Specific Receptors of the Liver
Ashwell, G., & Harford, J. (1982) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.51.070182.002531 · Cited by 1,914
The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Bilheimer, D. W., Eisenberg, S., & Levy, R. I. (1972) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(72)90034-3 · Cited by 1,815
Alberts, A. W., Chen, J., Kuron, G. W., Hunt, V. M., Huff, J. W., Hoffman, C., Rothrock, J. W., López, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,630
Flagged first, then by citations
Research works printed but not linked: 13
- BAILEY, J.M., CIBA FOUNDATION SYMPOSIUM 12: 63 (1973).
- BROWN, M.S., RECENT PROGRESS IN HORMONE RESEARCH 35: 215 (1979).
- Calvert, G. D. F., Low Density Liproteins: 281 (1976).
- FREDRICKSON, D.S., HARVEY LECTURE SERIES 68: 185 (1974).
- Fredrickson, D. S., The Metabolic Basis of Inherited Disease: 545 (1972).
- GOFMAN, J.W., PLASMA 2: 413 (1954).
- GOLDSTEIN, J.L., LIPOPROTEIN RECEPTORS - GENETIC DEFENSE AGAINST ATHEROSCLEROSIS, CLINICAL RESEARCH 30: 417 (1982).
- KOVANEN, P.T., INCREASED BINDING OF LOW-DENSITY LIPOPROTEIN TO LIVER MEMBRANES FROM RATS TREATED WITH 17-ALPHA-ETHYNYL ESTRADIOL, JOURNAL OF BIOLOGICAL CHEMISTRY 254: 1367 (1979).
- Lehrman, M. A., Proceedings of the National Academy of Sciences of the United States of America 83: 3679 (1986).
- MULLER, C, ACTA MEDICA SCANDINAVICA 89: 75 (1938).
- ONCLEY, J.L., HARVEY LECTURES 50: 71 (1956).
- PALADE, G. E., JOURNAL OF APPLIED PHYSICS 24: 1424 (1953).
- SCHNEIDER, W.J., MOL BIOL MED 1: 353 (1983).
Cited by
Sorted by citations
Items 201–300 of 1,059
Matsuda, M., Korn, B. S., Hammer, R. E., Moon, Y.-A., Komuro, R., Horton, J. D., Goldstein, J. L., Brown, M. S., & Shimomura, I. (2001) · Genes & Development · doi:10.1101/gad.891301 · Cited by 303
Self-citationWilliams, S. E., Ashcom, J. D., Argraves, W. S., & Strickland, D. K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50384-2 · Cited by 285
Sterol Regulation of Fatty Acid Synthase Promoter
Bennett, M. K., López, J. M., Sanchez, H. B., & Osborne, T. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25578 · Cited by 334
Sniderman, A. D., Scantlebury, T., & Cianflone, K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00014 · Cited by 331
Ma, P. T. S., Gil, G., Südhof, T. C., Bilheimer, D. W., Goldstein, J. L., & Brown, M. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8370 · Cited by 334
Self-citationLu, F., Liang, Q., Abi-Mosleh, L., Das, A., De Brabander, J. K., Goldstein, J. L., & Brown, M. S. (2015) · eLife · doi:10.7554/elife.12177 · Cited by 333
Self-citationBiochemistry and cell biology of mammalian scavenger receptors
Murphy, J. E., Tedbury, P. R., Homer‐Vanniasinkam, S., Walker, J. H., & Ponnambalam, S. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.036 · Cited by 331
Genest, J. J., McNamara, J. R., Ordovás, J. M., Jenner, J. L., Silberman, S. R., Anderson, K. M., Wilson, P. W. F., Salem, D. N., & Schaefer, E. J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90520-w · Cited by 333
Mukherjee, S., Zha, X., Tabas, I., & Maxfield, F. R. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77632-5 · Cited by 300
Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron
Goritz, C., Mauch, D. H., & Pfrieger, F. W. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.02.006 · Cited by 330
Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer
Guo, D., Bell, E. H., Mischel, P. S., & Chakravarti, A. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990486 · Cited by 333
Molecular Mechanisms of Inherited Cardiomyopathies
Fatkin, D., & Graham, R. M. (2002) · Physiological Reviews · doi:10.1152/physrev.00012.2002 · Cited by 328
Nigon, F., Lesnik, P., Rouis, M., & Chapman, M. J. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41629-3 · Cited by 325
Fuhrman, B., Elis, A., & Aviram, M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6520 · Cited by 323
Human Apolipoprotein E Receptor 2
Kim, D.-H., Iijima, H., Goto, K., Sakai, J., Ishii, H., Kim, H.-J., Suzuki, H., Kondo, H., Saeki, S., & Yamamoto, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8373 · Cited by 384
Worgall, T. S., Sturley, S. L., Seo, T., Osborne, T. F., & Deckelbaum, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25537 · Cited by 322
Liscum, L., & Faust, J. R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80136-3 · Cited by 322
Ghosh, R. K., & Webb, W. W. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80939-7 · Cited by 321
Apolipoprotein E: From lipid transport to neurobiology
Hauser, P. S., Narayanaswami, V., & Ryan, R. O. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.09.001 · Cited by 320
Inflammation in Atherosclerosis—No Longer a Theory
Libby, P. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa275 · Cited by 333
Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study
Lahoz, C., Schaefer, E. J., Cupples, L. A., Wilson, P. W. F., Levy, D. A., Osgood, D. P., Parpos, S., Pedro‐Botet, J., Daly, J. A., & Ordovás, J. M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00570-0 · Cited by 319
Regulation of gene expression by SREBP and SCAP
Edwards, P. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00140-2 · Cited by 316
Li, W., Tanimura, M., Luo, C. C., Datta, S., & Chan, L. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38532-1 · Cited by 316
Bu, G., Williams, S. E., Strickland, D. K., & Schwartz, A. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7427 · Cited by 315
Manna, P. R., Dyson, M. T., & Stocco, D. M. (2009) · Molecular Human Reproduction · doi:10.1093/molehr/gap025 · Cited by 328
All roads lead to PP 2A: exploiting the therapeutic potential of this phosphatase
Sangodkar, J., Farrington, C. C., McClinch, K., Galsky, M. D., Kastrinsky, D. B., & Narla, G. (2016) · The FEBS Journal · doi:10.1111/febs.13573 · Cited by 312
Two Mutant Alleles of the Insulin Receptor Gene in a Patient with Extreme Insulin Resistance
Kadowaki, T., Bevins, C. L., Cama, A., Ojamaa, K., Marcus‐Samuels, B., Kadowaki, H., Beitz, L., McKeon, C., & Taylor, S. I. (1988) · Science · doi:10.1126/science.2834824 · Cited by 308
Rapid manufacturing of non-activated potent CAR T cells
Ghassemi, S., Durgin, J. S., Nuñez-Cruz, S., Patel, J., Leferovich, J. M., Pinzone, M. R., Shen, F., Cummins, K. D., Plesa, G., Cantu, V. A., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00842-6 · Cited by 316
Hazell, L. J., & Stocker, R. (1993) · Biochemical Journal · doi:10.1042/bj2900165 · Cited by 311
Alexander, A. G., Marfil, V., & Li, C. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00279 · Cited by 310
Liang, W. S., Dunckley, T., Beach, T. G., Grover, A., Mastroeni, D., Ramsey, K., Caselli, R. J., Kukull, W. A., McKeel, D., Morris, J. C., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00242.2007 · Cited by 309
Outsourcing in the brain: Do neurons depend on cholesterol delivery by astrocytes?
Pfrieger, F. W. (2003) · BioEssays · doi:10.1002/bies.10195 · Cited by 308
Regulation of glucose and lipid metabolism in health and disease
Chen, L., Chen, X., Huang, X., Song, B., Wang, Y., & Wang, Y. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-1563-3 · Cited by 313
Liscum, L., Ruggiero, R. M., & Faust, J. R. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.5.1625 · Cited by 307
Jing, S. Q., Spencer, T. E., Miller, K., Hopkins, C. R., & Trowbridge, I. S. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.110.2.283 · Cited by 304
Regulation of HMG-CoA reductase in mammals and yeast
Burg, J. S., & Espenshade, P. J. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.07.002 · Cited by 303
Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver.
Sheng, Z., Otani, H., Brown, M. S., & Goldstein, J. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.935 · Cited by 265
Self-citationThe effect of diet on plasma lipids, lipoproteins, and coronary heart disease
Kris‐Etherton, P. M., Krummel, D. A., Russell, M. E., Dreon, D. M., Mackey, S., Borchers, J., & Wood, P. D. (1988) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)08023-8 · Cited by 301
Varban, M. L., Rinninger, F., Wang, N., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Gosselin, M. L., Dixon, K. L., Deeds, J. D., Acton, S. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4619 · Cited by 303
Hua, X., Wu, J., Goldstein, J. L., Brown, M. S., & Hobbs, H. H. (1995) · Genomics · doi:10.1016/0888-7543(95)80009-b · Cited by 297
Self-citationCommon low-density lipoprotein receptor mutations in the French Canadian population.
Leitersdorf, E., Tobin, E. J., Davignon, J., & Hobbs, H. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114531 · Cited by 297
Vesicular and non-vesicular sterol transport in living cells
Hao, M., Lin, S. X., Karylowski, O. J., Wüstner, D., McGraw, T. E., & Maxfield, F. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108861200 · Cited by 285
The role of cholesterol metabolism in cancer.
Ding, X., Zhang, W., Li, S., & Yang, H. (2019) · Europe PMC (PubMed Central) · Cited by 301
The clinical investigator: bewitched, bothered, and bewildered--but still beloved.
Goldstein, J. L., & Brown, M. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119470 · Cited by 298
Self-citationZhou, Z., Gong, Q., & January, C. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31123 · Cited by 298
Intracellular cholesterol transport
Soccio, R. E., & Breslow, J. L. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000131264.66417.d5 · Cited by 297
Assembly and secretion of hepatic very-low-density lipoprotein
Gibbons, G. F. (1990) · Biochemical Journal · doi:10.1042/bj2680001 · Cited by 294
Sanchez, H. B., Yieh, L., & Osborne, T. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1161 · Cited by 257
Plasma homocyst(e)ine levels in men with premature coronary artery disease
Genest, J. J., McNamara, J. R., Salem, D. N., Wilson, P. W. F., Schaefer, E. J., & Malinow, M. R. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90542-w · Cited by 297
Role of cholesterol in the function and organization of G-protein coupled receptors
Pucadyil, T. J., & Chattopadhyay, A. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.02.002 · Cited by 300
Zock, P. L., de Vries, J. H. M., & Katan, M. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.567 · Cited by 293
Dynasore - not just a dynamin inhibitor
Preta, G., Cronin, J., & Sheldon, I. M. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0102-1 · Cited by 292
Tufail, M., & Takeda, M. (2008) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2008.11.007 · Cited by 288
Yoshida, H., & Kisugi, R. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.08.038 · Cited by 289
Hixson, J. E. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1237 · Cited by 286
The peroxisome: an update on mysteries 2.0
Islinger, M., Völkl, A., Fahimi, H. D., & Schrader, M. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1722-5 · Cited by 296
Nascent astrocyte particles differ from lipoproteins in CSF
LaDu, M. J., Gilligan, S. M., Lukens, J. R., Cabana, V. G., Reardon, C. A., Van Eldik, L. J., & Holtzman, D. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052070.x · Cited by 285
PCSK9: From Basic Science Discoveries to Clinical Trials
Shapiro, M. D., Tavori, H., & Fazio, S. (2018) · Circulation Research · doi:10.1161/circresaha.118.311227 · Cited by 285
Sehayek, E., & Eisenberg, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55263-7 · Cited by 249
Nitta, M., Ku, S., Brown, C., Okamoto, A. Y., & Shan, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6660 · Cited by 279
The peroxisome: an update on mysteries
Islinger, M., Grille, S., Fahimi, H. D., & Schrader, M. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0941-4 · Cited by 283
Lehrman, M. A., Schneider, W. J., Brown, M. S., Davis, C. G., Elhammer, Å. P., Russell, D. W., & Goldstein, J. L. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75941-9 · Cited by 282
Self-citationDNA Diagnostics—Molecular Techniques and Automation
Landegren, U. D., Kaiser, R., Caskey, C. T., & Hood, L. (1988) · Science · doi:10.1126/science.3051381 · Cited by 280
Role of Oxidized LDL in Atherosclerosis
Kita, T., Kume, N., Minami, M., Hayashida, K., Murayama, T., Sano, H., Moriwaki, H., Kataoka, H., Nishi, E., Horiuchi, H., et al. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03941.x · Cited by 284
Role of Orphan Nuclear Receptors in the Regulation of Drug-Metabolising Enzymes
Wang, H., & LeCluyse, E. L. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342150-00003 · Cited by 284
Pharmacology of competitive inhibitors of HMg-CoA reductase
Corsini, A. (1995) · Pharmacological Research · doi:10.1016/1043-6618(95)80042-5 · Cited by 275
Nebert, D. W. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-9-1203 · Cited by 273
Santos, R. D. (2001) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2001001500001 · Cited by 264
Kim, J., Castellano, J. M., Jiang, H., Basak, J. M., Parsadanian, M., Pham, V., Mason, S. M., Paul, S. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.11.013 · Cited by 274
Greeve, J. C., Altkemper, I., Dieterich, J., Greten, H., & Windler, E. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36966-2 · Cited by 274
Poirier, S., Mayer, G., Poupon, V., McPherson, P. S., Desjardins, R., Ly, K., Asselin, M.-C., Day, R., Duclos, F. J., Witmer, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.037085 · Cited by 254
Kozyraki, R., Fyfe, J. C., Kristiansen, M., Gerdes, C., Jacobsen, C. B., Cui, S., Christensen, E., Aminoff, M., de la Chapelle, A., Krahe, R., et al. (1999) · Nature Medicine · doi:10.1038/9504 · Cited by 273
Chan, P. T., Fong, W. P., Cheung, Y. L., Huang, Y., Ho, W. K. K., & Chen, Z. (1999) · Journal of Nutrition · doi:10.1093/jn/129.6.1094 · Cited by 272
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
Behbodikhah, J., Ahmed, S., Elyasi, A., Kasselman, L. J., Leon, J. D., Glass, A. D., & Reiss, A. B. (2021) · Metabolites · doi:10.3390/metabo11100690 · Cited by 299
Stein, E. A., Illingworth, D. R., Kwiterovich, P. O., Liacouras, C. A., Siimes, M. A., Jacobson, M. S., Brewster, T. G., Hopkins, P. N., Davidson, M. H., Graham, K. J., et al. (1999) · JAMA · doi:10.1001/jama.281.2.137 · Cited by 272
Wasan, K. M., Brocks, D. R., Lee, S. D., Sachs‐Barrable, K., & Thornton, S. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2353 · Cited by 270
McCrindle, B. W., Ose, L., & Marais, A. (2003) · The Journal of Pediatrics · doi:10.1016/s0022-3476(03)00186-0 · Cited by 270
Huh, H., Pearce, S., Yesner, L. M., Schindler, J., & Silverstein, R. (1996) · Blood · doi:10.1182/blood.v87.5.2020.2020 · Cited by 269
Importance of growth hormone for the induction of hepatic low density lipoprotein receptors.
Rudling, M. J., Norstedt, G., Olivecrona, H., Reihnér, E., Gustafsson, J.-Α., & Angelin, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6983 · Cited by 266
LDL receptor‐related protein: a multiligand receptor for lipoprotein and proteinase catabolism
Strickland, D. K., Kounnas, M. Z., & Argraves, W. S. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615159 · Cited by 268
Hazell, L. J., van den Berg, J. J. M., & Stocker, R. (1994) · Biochemical Journal · doi:10.1042/bj3020297 · Cited by 267
Vimentin Diversity in Health and Disease
Danielsson, F., Peterson, M. P., Caldeira, H., Lautenschläger, F., & Gad, A. K. B. (2018) · Cells · doi:10.3390/cells7100147 · Cited by 276
Sakai, J., Hoshino, A., Takahashi, S., Miura, Y., Ishii, H., Suzuki, H., Kawarabayasi, Y., & Yamamoto, T. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42151-x · Cited by 268
Eskelinen, E., Schmidt, C. K., Neu, S., Willenborg, M., Fuertes, G., Salvador-Montoliu, N., Tanaka, Y., Lüllmann‐Rauch, R., Hartmann, D., Heeren, J., et al. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-02-0103 · Cited by 272
Dawson, P. A., Hofmann, S. L., van der Westhuyzen, D. R., Südhof, T. C., Brown, M. S., & Goldstein, J. L. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69081-7 · Cited by 266
Self-citationHan, J., Hajjar, D. P., Febbraio, M., & NICHOLSON, A. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21654 · Cited by 265
Zeisel, M. B., Koutsoudakis, G., Schnober, E. K., Haberstroh, A., Blum, H. E., Cosset, F., Wakita, T., Jaeck, D., Doffoël, M., Royer, C., et al. (2007) · Hepatology · doi:10.1002/hep.21994 · Cited by 262
Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia.
Austin, M. A., Brunzell, J. D., Fitch, W. L., & Krauss, R. M. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.4.520 · Cited by 262
Grünler, J., Ericsson, J., & Dallner, G. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90200-3 · Cited by 259
Biokinetics of and discrimination between dietaryRRR‐ andSRR‐α‐tocopherols in the male rat
Ingold, K. U., Burton, G. W., Foster, D. O., Hughes, L., Lindsay, D. A., & Webb, A. C. (1987) · Lipids · doi:10.1007/bf02537297 · Cited by 261
Steroids in Molecular Recognition
Wallimann, P., Marti, T., Fürer, A., & Diederich, F. (1997) · Chemical Reviews · doi:10.1021/cr960373b · Cited by 260
Schaefer, E. J., Lamon‐Fava, S., Cohn, S. D., Schaefer, M. M., Ordovás, J. M., Castelli, W. P., & Wilson, P. W. F. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39173-2 · Cited by 259
Diagnosis and treatment of familial hypercholesterolaemia
Hovingh, G. K., Davidson, M. H., Kastelein, J. J. P., & O’Connor, A. M. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht015 · Cited by 265
Obesity and Insulin Resistance
Després, J., & Marette, A. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-716-1_4 · Cited by 254
Kawamura, M., Heinecke, J. W., & Chait, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117396 · Cited by 255
Modulation of Secreted β-Amyloid Precursor Protein and Amyloid β-Peptide in Brain by Cholesterol
Howland, D., Trusko, S. P., Savage, M. J., Reaume, A. G., Lang, D. M., Hirsch, J. D., Maeda, N., Siman, R., Greenberg, B., Scott, R. W., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16576 · Cited by 256
Wilcox, L. J., Borradaile, N. M., de Dreu, L. E., & Huff, M. W. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31634-5 · Cited by 254
Helgadóttir, A., Grétarsdóttir, S., Þorleifsson, G., Hjartarson, E., Sigurðsson, Á., Magnusdottir, A., Jónasdóttir, Á., Kristjansson, H., Sulem, P., Oddsson, Á., et al. (2016) · Nature Genetics · doi:10.1038/ng.3561 · Cited by 248
Heino, S., Lusa, S., Somerharju, P. J., Ehnholm, C., Olkkonen, V. M., & Ikonen, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140218797 · Cited by 257
Wang, N., Tabas, I. A., WINCHESTER, R. J., Stefano Ravalli, A., Rabbani, L. E., & Tall, A. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8837 · Cited by 252
Metadata
- Authors
- Brown, M. S., & Goldstein, J. L.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Science
- Published
- 1986-04-04
- Volume
- 232
- Issue
- 4746
- Pages
- 34-47
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2084744450
- Semantic Scholar
- 272a968782c9511ffde67976c781969ead33e19e
- Cited by
- 5,703
- References
- 151
- Citations by year
- 2026: 64 · 2025: 78 · 2024: 61 · 2023: 105 · 2022: 107 · 2021: 125 · 2020: 118 · 2019: 108 · 2018: 131 · 2017: 140 · 2016: 130 · 2015: 145 · 2014: 139 · 2013: 134 · 2012: 139
- FWCI
- 30.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cholesterol homeostasis, cholesterol metabolism, lipid transport
- MeSH terms
- Biological Transport, Cholesterol, Endocytosis, Homeostasis, Humans, Hyperlipoproteinemia Type II, Kinetics, Lipid Metabolism, Inborn Errors, Lipoproteins, HDL, Lipoproteins, LDL, Models, Biological, Mutation, Receptors, LDL
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
